The combination of cyproterone acetate and low dose diethylstilbestrol in the treatment of advanced prostatic carcinoma.
about
Hormonal therapy for stage D cancer of the prostateGPRC6A regulates prostate cancer progressionRandomized phase 2 study of bone-targeted therapy containing strontium-89 in advanced castrate-sensitive prostate cancer.Advances in diagnosis and management of prostate cancer.Carcinoma of the Prostate: Screening and investigative techniques and treatments.Urokinase- and tissue-type plasminogen activators are suppressed by cortisol in the involuting prostate of castrated rats.SEMA3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1.
P2860
Q33607710-03CA1F2C-80F5-4FB6-82DC-417E268A207AQ34193432-8B34351A-2E8A-4638-8200-C28E4A1A13ABQ34734425-79EE964E-EB29-409E-B084-8217CDB8A4F5Q36520348-EE8C8370-FFF4-499A-9671-3CA0D4E16CBCQ39966419-D60FB743-3C9C-47CD-8694-20F08DC31E5EQ42794619-430B0AB2-4668-4431-A535-8614A67E55B2Q48216846-344026FE-4FB4-4AEF-95EA-0E1E45773D05
P2860
The combination of cyproterone acetate and low dose diethylstilbestrol in the treatment of advanced prostatic carcinoma.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
The combination of cyproterone ...... advanced prostatic carcinoma.
@en
type
label
The combination of cyproterone ...... advanced prostatic carcinoma.
@en
prefLabel
The combination of cyproterone ...... advanced prostatic carcinoma.
@en
P2093
P1476
The combination of cyproterone ...... advanced prostatic carcinoma.
@en
P2093
C M Coppin
N Bruchovsky
P S Rennie
S L Goldenberg
P304
P407
P577
1988-12-01T00:00:00Z